3.260USDMkt Cap: 8.03M USDP/E: —Last update: 2026-05-21
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The c…
Industry Peers
Health Information Servicesloading…
Indicators:|
Key Statistics
Company
Market Cap8.03M USD
Enterprise Value-10.98M USD
Revenue (TTM)77.88K USD
Gross Profit6.83K USD
Net Income (TTM)-7.23M USD
Revenue/Share0.0770 USD
Last Price3.260 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.24
PEG—
EV/EBITDA1.32
EV/Revenue-140.96
P/S103.07
P/B0.41
EPS (TTM)-5.63
EPS (Forward)-13.71
52W Range
3.18080% of range3.280
52W High3.280 USD
52W Low3.180 USD
Profitability
Gross Margin9.02%
Oper. Margin-14129.33%
EBITDA Margin0.00%
Profit Margin-9551.87%
ROE-56.36%
ROA-52.91%
Growth
Revenue Growth11.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.16M USD
CapEx (TTM)203.90K USD
FCF Margin-6235.17%
FCF Yield-60.49%
Net Debt-19.00M USD
Net Debt/EBITDA2.29
Balance Sheet
Debt/Equity—
Current Ratio19.65
Quick Ratio19.31
Book Value/Sh8.039 USD
Cash/Share7.719 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:27
Split DateMar 28, 2025
Analyst Consensus
Rating—
Target (Mean)7.000 USD
Target Range7.000 USD – 7.000 USD
# Analysts1
Ownership
Shares Out.2.46M
Float2.21M
Insiders10.56%
Institutions4.63%
Short Interest
Short Ratio1.8d
Short % Float10.68%
Short % Out.10.68%
Shares Short262.95K
Short (prev mo.)142.28K
Technical
SMA 503.299 (-1.2%)
SMA 2005.321 (-38.7%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)15.62K
Avg Vol (10d)35.15K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—